SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001116679-07-000167
Filing Date
2007-01-16
Accepted
2007-01-16 16:21:09
Documents
1
Period of Report
2007-01-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3939
  Complete submission text file 0001116679-07-000167.txt   5835
Mailing Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154
Business Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154 212-750-6700
BIOENVISION INC (Issuer) CIK: 0001028205 (see all company filings)

IRS No.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address THE CEDARS HOLLYBRUSH HILL STOKE POGES BUCKS UK SL2 AQN
Business Address 011441718397570
WOOD CHRISTOPHER B (Reporting) CIK: 0001099455 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31787 | Film No.: 07532264